Related Experiment Videos
[Hepatic adenoma and oral contraception]
Summary
Oral contraceptives are linked to liver adenoma development in women. Long-term oral contraceptive use may cause liver hyperactivity and hypertrophy, posing clinical challenges and risks like bleeding.
Area of Science:
- Hepatology
- Endocrinology
- Oncology
Background:
- Oral contraceptives (OCs) contain oestrogen and progesterone.
- Prolonged OC use is common among women of reproductive age.
- Liver adenomas are rare tumors, but their association with OCs is recognized.
Observation:
- Two new cases of liver adenoma in women using OCs are presented.
- A review of 31 previously reported cases of liver adenoma associated with OCs was conducted.
- The study analyzes theoretical and practical issues related to liver adenomas in OC users.
Findings:
- Uninterrupted, long-term OC use may lead to liver hyperactivity to neutralize excess hormones.
- This hormonal imbalance can result in liver gland hypertrophy, forming adenomas.
- The risk of acute intraperitoneal bleeding is a significant complication of liver adenomas.
Implications:
- Clinicians must be vigilant in supervising women on long-term OCs.
- Abdominal examinations are crucial for early detection of potential liver abnormalities.
- Gynecologists and surgeons need awareness of OC-associated liver tumors and bleeding risks.